While back pain can cause tremendous discomfort, it isn't a disease on its own. It can, however, be a sign that you have a ...
Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines ...
Experimental, drug-free, MRI-guided cancer treatment may one day offer a way of targeting and destroying pancreatic tumors ...
Preliminary results have fueled hope for a new cancer drug from Revolution Medicines while posing a test for the Trump ...
NYU Langone Health researchers found that a type of cell death caused by a buildup of highly reactive molecules suppresses ...
Presented positive data from Phase 1 clinical trials with ARV-102 in healthy volunteers and patients with Parkinson’s disease - ...
REDWOOD CITY, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...
The Company, under the leadership of its new CEO, Diede van den Ouden, who joined in the June 2025, is currently undertaking a strategic restructuring with the goal of providing the financial ...